cancer research
Article by Fashion201104
The debut sample issue will feature study that enhances the classification of prostate cancer and proposes a probable new therapy, introduces possible new targets for lung cancer, and redefines immunotherapy in breast cancer.
Co-editors in Chief Lewis Cantley, Ph.D., director of the Beth Israel Deaconess Medical Center and professor of Systems Biology at Harvard Medical School, and Jose Baselga, M.D., Ph.D., associate director and chief of the division of hematology/oncology at the Massachusetts General Hospital, will host a press conference on these studies and discuss the implications of the new journal for the field. This press conference is going to be held on Sunday, April three at 1:00 p.m. ET in Room W313 of the Orange County Convention Center.
??ãCancer Discovery is poised to create major contributions to the growing body of expertise. These papers are examples of the practice-changing research we can expect from this esteemed journal,? said Cantley. The mission of the American Association for Cancer Study would be to avoid and cure cancer. Founded in 1907, the AACR is the world? oldest and largest expert organization dedicated to advancing cancer study. The membership consists of 32,000 basic, translational and clinical researchers; health care experts; and cancer survivors and advocates within the United States and additional than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer via high-quality scientific and educational programs. It funds innovative, meritorious investigation grants, study fellowships and career development awards. The AACR Annual Meeting attracts far more than 18,000 participants who share the latest discoveries and developments in the field. Unique conferences throughout the year present novel data across a wide variety of topics in cancer investigation, treatment and patient care. Including Cancer Discovery, the AACR publishes seven significant peer-reviewed journals: Cancer Investigation; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. AACR journals represented 20 percent of the market share of total citations in 2009. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists.
About the Author
Let’s have a good understanding of cancer.